Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
NHRC Proposes Central Drug Registry and Pharmacy License Ratio to Curb Counterfeit Medicines

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Politics

NHRC Proposes Central Drug Registry and Pharmacy License Ratio to Curb Counterfeit Medicines

Analysed 24 Sept 2026·3 sources analysed·India·Politics
NHRC Proposes Central Drug Registry and Pharmacy License Ratio to Curb Counterfeit MedicinesPreviousNext

The National Human Rights Commission (NHRC) has recommended establishing a centralized digital registry for medicines in India to combat counterfeit drugs. The system would use dynamic, uniquely serialized QR codes and a trace-and-track portal to monitor drug movement, initially focusing on high-risk and life-saving medicines. Additionally, the government is considering setting a retail-to-wholesale pharmacy license ratio based on population and disease burden to standardize licensing and prevent misuse of wholesale permits. These measures aim to enhance drug safety and regulatory uniformity across states.

Sentiment
57%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (57/100). Lens Score 59/100.

Outlets measured: mint, mint, economictimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 24 Sept 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (57/100)

Sentiment was consistent across outlets (52–62/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

economictimes broke this story on 23 Sept, 06:54 pm. Other outlets followed.

23 Sept, 06:54 pm3 sources · 11 h24 Sept, 06:16 am
AI analysis by the TBN Bias Engine · beat methodology byPrajakta Kale· Political Analyst· editorial standards byOjas Kale
← Previous
Supreme Court Collegium Approves 12 Judges as Permanent in Four High Courts
Next →
China's Economic and Military Support to Iran Challenges US Sanctions Efforts
  1. 1
    economictimes23 Sept, 06:54 pm
    NHRC proposes central drug registry, real-time tracking to curb spurious medicines
  2. 2
    mint24 Sept, 12:47 am
    India mulls a wholesale-retail pharmacy ratio to curb misuse Today News
  3. 3
    mint24 Sept, 06:16 am
    Mint Explainer Why NHRC wants India's drugs regulator to build a national digital registry Mint

Accountability flags

TBN's analysis identified the following accountability dimensions in this story.

  • public safety issue

    This story involves a risk to public safety — infrastructure failure, regulatory lapse, hazardous conditions, or emergency mishandling.

Who's involved

Institutions and figures named across source coverage.

Government
Delhi PoliceDrugs Controller General of IndiaMinistry of HealthState Licensing AuthoritiesCentral Drugs Standard Control OrganisationKarnataka Food and Drug AdministrationNational Human Rights Commission
Enforcement
Delhi PoliceKarnataka Food and Drug Administration

Story context

Category
Politics
Location
India
Sources analysed
3
Last analysed
24 Sept 2026
Key entities
IndiaSupply chainNational Human Rights Commission of IndiaQR codeDrugs Controller General of IndiaAuthenticationThe National (Abu Dhabi)Mint (newspaper)Counterfeit medicationsUnion territoryGovernment of IndiaMedication